FLAG chemotherapy followed by allogeneic stem cell transplant using nonmyeloablative conditioning induces regression of myelofibrosis with myeloid metaplasia

Bone Marrow Transplantation

Volumn 32, Issue 6, 2003, Pages 581-585

  Tanner, M L ^a   Hoh, C K ^a   Bashey, A ^a   Holman, P ^a   Sun, C ^a   Broome, H E ^a   Lane, T ^a   Ball, E D ^a   Carrier, E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Allogeneic stem cell transplantation; Myelofibrosis; Technetium sulfur colloid scan

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; BUSULFAN; CYTARABINE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; METHOTREXATE; MYCOPHENOLIC ACID; PREDNISONE; TACROLIMUS; TECHNETIUM SULFUR COLLOID TC 99M; THYMOCYTE ANTIBODY;

ABDOMINAL PAIN; ADULT; AGE; ALLOGRAFT; ANEMIA; ARTICLE; AUTOIMMUNE DISEASE; BONE MARROW; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CASE REPORT; DISEASE SEVERITY; DONOR; DRUG BLOOD LEVEL; FEMALE; GASTROINTESTINAL DISEASE; GENDER; GRAFT VERSUS HOST REACTION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATOSPLENOMEGALY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LIVER DISEASE; MYELOFIBROSIS; MYELOID METAPLASIA; OSTEOSCLEROSIS; PRIORITY JOURNAL; PROGNOSIS; SCINTISCANNING; SIBLING; TIME; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYTARABINE; FEMALE; GRAFT VS HOST DISEASE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MYELOFIBROSIS; MYELOID METAPLASIA; OSTEOSCLEROSIS; REMISSION INDUCTION; SPLENOMEGALY; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; VIDARABINE;

EID: 0141837081     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704172     Document Type: Article

References (15)

1. Tefferi A. Myelofibrosis with myeloid metaplasia. N Engl J Med 2000; 342: 1255-1265.
2. Smith BD, Moliterno A. Biology and management of idiopathic myelofibrosis. Curr Opin Oncol 2001; 13: 91-94.
3. Anderson JE, Tefferi A, Craig F et al. Myeloablation and autologous peripheral blood stem cell rescue results in hematologic and clinical responses in patients with myeloid metaplasia with myelofibrosis. Blood 2001; 98: 586-593.
4. Guardiola P, Anderson JE, Bandini G et al. Allogeneic stem cell transplantation for agnogenic myeloid metaplasia: a European group for blood and marrow transplantation, Societe Francaise de Greffe de Moelle, Gruppo Italiano per il Trapianto del Modello Osseo, and Fred Hutchinson Cancer Research Center Collaborative Study. Blood 1999; 93: 2831-2838.
5. Ramakrishna R, Kyle PW, Day PJ, Manoharan A. Evans' syndrome, myelofibrosis, and systemic lupus erythematosus: role of procollagens in myelofibrosis. Pathology 1995; 27: 255-259.
6. Paquette R, Meshkinpour A, Rosen P. Autoimmune myelofibrosis: a steroid-responsive cause of bone marrow fibrosis associated with systemic lupus erythematosus. Medicine 1994; 73: 145-152.
7. Maris M. Nonmyeloablative allogeneic hematopoietic stem cell transplantation. Fellow Reporter 2001; 6: 59-62.
8. Cervantes F, Barosi G, Demory JL et al. Myelofibrosis with myeloid metaplasia in young individuals: disease characteristics, prognostic factors, and identification of risk groups. Br J Haematol 1998; 102: 684-690.
9. Slavin S, Nagler A, Naparstek E et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 1998; 91: 756-763.
10. Tefferi A, Messa RA, Nagorney DM et al. Splenectomy in myelofibrosis with myeloid metaplasia: a single-institution experience with 223 patients. Blood 2000; 95: 2226-2233.
11. Li Z, Deeg HJ. Pros and cons of splenectomy in patients with myelofibrosis undergoing stem cell transplantation. Leukemia 2001; 15: 465-467.
12. Coates GG, Eisenberg B, Dail DH. Tc-99m sulfur colloid demonstration of diffuse pulmonary interstitial extramedullary hematopoiesis in a patient with myelofibrosis: a case report and review of the literature. Clin Nucl Med 1994; 19: 1079-1084.
13. Kucuk O, Gordon LI, Kies MS et al. Estimation of hematopoietic potential by CFU-c and bone marrow scan in cancer patients. Exp Hematol 1984; 12: 101-106.
14. Derin H, Yetkin E, Ozkilic H et al. Detection of splenosis by radionuclide scanning. Br J Radiol 1987; 60: 873-875.
15. Dumarey N, Martin P, Jayankura M et al. A 'made in one piece' skeleton in a 22-year-old man suffering from sickle cell anaemia. Clin Rheumatol 2000; 19: 287-290.